-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 7, 2021, Corning Jereh Biopharmaceuticals (stock code: 9966.
Esophageal cancer is one of the most common malignant tumors in the world.
KN046-204 includes 3 cohorts, one of which enrolls patients with unresectable locally advanced, recurrent or metastatic ESCC who have not received systemic treatment in the past and confirmed by histology or cytology (ECOG PS 0-1 points)
As of January 14, 2021, a total of 15 patients were enrolled in this cohort, all of whom were male, 52.
Note: The original text has been deleted